DOP023 Predictors of clinical and endoscopic response with...

Journal of Crohn's and Colitis 2017 / 02 Vol. 11; Iss. suppl_1

DOP023 Predictors of clinical and endoscopic response with vedolizumab for the treatment of moderately-severely active ulcerative colitis: results from the US VICTORY consortium

Dulai, P., Meserve, J., Hartke, J., Chilukuri, P., Chaudrey, K., Koliani-Pace, J.L., Kochhar, G., Parikh, M.P., Shmidt, E., Hirten, R., Luo, M., Barocas, M., Lasch, K., Sultan, K., Swaminath, A., Bohm
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx002.060
Date:
February, 2017
File:
PDF, 213 KB
english, 2017
Conversion to is in progress
Conversion to is failed